Skip to content

2020 Laureate Symposium Program

Radiological-pathological correlations in lung adenocarcinoma: qualitative and quantitative approaches

Constance de Margerie-Mellon
Éric de Kerviler (Hôpital Saint-Louis, Paris)
Alexander Banquier (Beth Israel Hospital, Boston)

Preclinical study of the immunogenic potential of DNA repair inhibitors in Non-Small Cell Lung Cancer: towards the development of innovative therapeutic combinations with immunotherapy

Roman Chabanon, Jean-Charles Soria (Institut Gustave Roussy, Villejuif)
Jean-Charles Soria (Institut Gustave Roussy, Villejuif)
Christopher Lord (The Institute of Cancer Research, London)

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Jean-Yves Delattre (Hôpital Pitié-Salpêtrière, Paris)
Jean-Yves Delattre (Hôpital Pitié-Salpêtrière, Paris)
Keith L. Ligon (Dana Farber Cancer Institute, Boston)

Development of new sequences in ultra-high field resolution (7T) MRI, and clinical validation in ophthalmologic oncology

Augustin Lecler
Jean-Claude Sadik (Fondation Rothchild, Paris)
Brian Rutt (Center of Imaging, Stanford)

Burkitt lymphoma: role of EBV, HIV and Plasmodium falciparium culture in vivo, and development of an in vitro model

Fatimata Bintou Sall
Awa Oumar Touré (Hôpital A. Le Dantec, Dakar)
Joëlle Wiels (Institut Gustave Roussy, Villejuif)

Preclinical evaluation of 64Cu-DOTHA2-PSMA-617 for theranosticsin prostate cancer

Ophélie Bélissant Benesty
Jean-Noël Talbot (Hôpital Tenon, Paris)
Éric Turcotte (Centre hospitalier universitaire de Sherbrooke, Québec)

Premature coronary artery disease: natural history, prognosis, primary and secondary risk factors

Michel Zeitouni
Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris)
Matthew T. Roe (Duke Institute, Durham)

Prediction of long-term coronary risk after TIA and cerebral infarction

Marion Boulanger
Emmanuel Touzé (Université de Caen)
Peter Rothwell (John Radcliff Hospital, Oxford)

Study of functional decline in an older population from the MAPT trial (Multidomain Alzheimer Preventive Trial)

Jagadish Kumar Chhetri
Bill Piu Chan (Xuan Wu Hospital, Beijing
Bruno Vellas (Gérontopole, Toulouse)

Identification and functional analysis of disease causing gene mutations that control macrophage functions in families with severe Systemic Lupus Erythematosus

Stéphanie Guillet
Bertrand Godeau (Hôpital Henri Mondor, Créteil)
Frédéric Geissmann (Mémorial Sloan Kettering Cancer Center, New-York)

Value of allogenic grafts of hematopoietic stem cells in primary immunodeficiency in adults with severe complications

Morgane Cheminant
Olivier Hermine (Hôpital Necker, Paris)
Siobhan Burns (UCL, London)

Thrombocytopinea at hospital admission and mortality risk. A population-based study in Denmark

Guillaume Moulis
Laurent Sailler (CHU Purpan, Toulouse)
Henrik Toft Sorensen (Aarhus University Hospital, Danemark)

Moderate hyperuricemia improves prognosis in acute ischemic renal failure via antioxidant action and metabolic reprogramming of macrophages

Viviane Gnemmi
Isabelle Van Seuningen (CHU Lille)
Hans-Joachim Anders (Klinikum der Universität München)

Alternative macrophages in vascular calcification: what is their role in type 2 diabetic subjects?

Cong Duy Le
Thanh Vy Tran (CHU d’Hô Chi Minh-City)
Giulia Chinetti (CHU de Nice)
Christophe Charpentier
General Manager of L’Institut Servier